Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731898 | SCV000859766 | uncertain significance | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868968 | SCV002202255 | likely benign | Rubinstein-Taybi syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485905 | SCV002777127 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-07-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004742619 | SCV005361426 | likely benign | CREBBP-related disorder | 2023-06-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |